Skip to main content
TipRanks
Go Ultimate75% OFF

Grace Life-tech Holdings Limited (2112) AI Stock Analysis

1 Followers
HK:2112

Grace Life-tech Holdings Limited

(HKEX:2112)

Select Model
Rating:38Underperform
Price Target:HKD 0.02â–²(0.00% Upside)
Action:reiterated
Date:11/14/26

Primarily impacted by poor financial performance with persistent losses and negative equity, alongside bearish technical signals and weak valuation metrics.

Positive Factors
Positive Gross MarginPositive gross margin indicates the company still generates some contribution from its revenue base, despite substantial operating losses. This provides a foundation for potential improvement if revenue stabilizes and costs become better aligned, although the current margin remains insufficient to support overall profitability.
Negative Factors
Persistent Losses and Revenue DeclineRecurring net losses combined with declining revenue indicate that the current business base is not yet producing sustainable earnings power. The shrinking top line can reduce operating leverage and make it harder to absorb fixed costs, prolonging losses unless growth and cost efficiency improve.

Grace Life-tech Holdings Limited (2112) vs. iShares MSCI Hong Kong ETF (EWH)

-80%-60%-40%-20%0%20%40%HK:2112-68.85%EWH+9.24%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
HKD 28.50M
Dividend Yield
―
Average Volume (3M)
1.03M
Price to Earnings (P/E)
-0.1
Beta (1Y)
0.70
Revenue Growth
-45.65%
EPS Growth
29.13%
Country
Hong Kong
Employees
46
Sector
Basic Materials
Sector Strength
61
Industry
Industrial - Distribution

Grace Life-tech Holdings Limited Business Overview & Revenue Model

Company Description

Grace Life-tech Holdings Limited, an investment holding company, engages in the research, development, and application of plant stem cell technology. It is also involved in the provision of health solutions and product sales in Hong Kong, the People’...

Grace Life-tech Holdings Limited Financial Statement Overview

Summary

Severe challenges including 19.3% revenue decline, -118.2% net profit margin, negative equity of -181.4 million, and negative cash flows highlight critical financial distress.

Income Statement

10Very Negative

Balance Sheet

5Very Negative

Cash Flow

15Very Negative
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue8.78M13.06M13.76M27.25M32.35M23.98M
Gross Profit1.18M1.48M2.17M2.85M2.54M164.00K
EBITDA-8.00M-7.50M-30.49M-23.74M-42.55M-44.21M
Net Income-27.50M-15.44M-48.13M-39.57M-55.74M-57.01M
Balance Sheet
Total Assets77.60M75.50M79.80M108.95M133.56M173.13M
Cash, Cash Equivalents and Short-Term Investments129.98K358.95K255.00K135.00K187.00K1.19M
Total Debt161.26M148.27M193.26M121.04M171.57M166.50M
Total Liabilities271.23M257.10M247.29M228.85M213.88M197.41M
Stockholders Equity-193.43M-181.42M-167.40M-119.90M-80.32M-24.27M
Cash Flow
Free Cash Flow-4.43M-372.55K-78.00K-53.00K-1.01M1.10M
Operating Cash Flow-4.43M-372.55K-75.00K-27.00K-1.00M1.41M
Investing Cash Flow00-3,000-26.00K-2,000-303.00K
Financing Cash Flow4.48M488.72K193.00K00-12.00K

Grace Life-tech Holdings Limited Technical Analysis

Technical Analysis SentimentNegative
Last Price0.02

Price Trends

50DMA0.03Negative
100DMA0.04Negative
200DMA0.05Negative

Market Momentum

MACD-0.00Positive
RSI7.59Positive
STOCH-6.06Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2112, the sentiment is Negative. The current price of 0.02 is below the 20-day moving average (MA) of 0.03, below the 50-day MA of 0.03, and below the 200-day MA of 0.05, indicating a bearish trend. The MACD of -0.00 indicates Positive momentum. The RSI at 7.59 is Positive, neither overbought nor oversold. The STOCH value of -6.06 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:2112.

Grace Life-tech Holdings Limited Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

HK:2112 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *61Neutral$10.43B7.12-0.05%2.87%2.86%-36.73%
HK:0609HK:060945NeutralHKD 821.32M13.952.08%3.19%16.60%-12.13%
HK:0301HK:030143NeutralHKD 3.70B-199.03-8.09%―3.15%50.74%
HK:8189HK:818940UnderperformHKD 213.39M-8.66-634.56%―53.32%-122.35%
HK:2112HK:211238UnderperformHKD 28.50M-0.1314.68%―-45.65%29.13%

* Basic Materials Sector Average

Performance Comparison

0%200%400%600%800%HK:2112HK:8189HK:0609HK:0301HK:0660HK:2565Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
HK:2112 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
HK:2112Grace Life-tech Holdings Limited0.02-0.04-69.35%
HK:8189Tianjin TEDA Biomedical Engineering Co. Ltd. Class H0.10-0.28-73.33%
HK:0609Tiande Chemical Holdings Limited0.94-0.41-30.43%
HK:0301SANVO Fine Chemicals Group Limited7.886.38425.00%
HK:0660Wai Chun Bio-Technology Ltd.0.390.1559.18%
HK:2565PegBio Co., Ltd. Class H2.85-61.75-95.59%

Grace Life-tech Holdings Limited Corporate Events

Grace Life-tech Publishes 2026 Interim Results Amid Ongoing Restructuring

Aug 31, 2026

Grace Life-tech Holdings Limited has released its unaudited interim results for the six months ended 30 June 2026, fulfilling Hong Kong listing requirements despite being under restructuring with joint provisional liquidators in place. The interim re...

Grace Life-tech Sets August Board Meeting to Approve Interim Results and Consider Dividend

Aug 18, 2026

Grace Life-tech Holdings Limited has scheduled a board meeting for 31 August 2026 to review and approve the interim results of the company and its subsidiaries for the six months ended 30 June 2026. The board will also consider the declaration of an...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 14, 2026